Aceclofenac/Diacerein/Glucosamine

醋氯芬酸/双醋瑞因/氨基葡萄糖

Report date: 2024/03/18 12:20:34

Base Information

Drug NameAceclofenac/Diacerein/Glucosamine
Drug Alias NameDiacerein/aceclofenac/glucosamine双醋瑞因/醋氯芬酸/氨基葡萄糖Diacerein+aceclofenac+glucosamine双醋瑞因+醋氯芬酸+氨基葡萄糖氨基葡萄糖/醋氯芬酸/双醋瑞因 +[10] 
ClassificationSmall molecules
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitorsInterleukin-1 beta inhibitorsCyclooxygenases inhibitors
TargetsNuclear factor NF-kappa-B complexInterleukin-1 betaCyclooxygenases
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes DiacereinGlucosamine HydrochlorideAceclofenac
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJenburkt Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJenburkt Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsOsteoarthritis

Other Information

ATC CodeN/A
Related LinksN/A